Guselkumab for Overlap Inflammatory Bowel Disease and Spondyloarthritis
Guselkumab for Overlap Inflammatory Bowel Disease and Spondyloarthritis
Not yet recruiting · NCT07602517 · Registry updated 2026-05-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Guselkumab for Overlap Inflammatory Bowel Disease and Spondyloarthritis | Digestive System Diseases, Spondylarthritis, arthritic joint disease, arthropathy, bone disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, musculoskeletal system disorder, spondylitis, spondyloarthropathy, vertebral column disorder | Not yet recruiting | Not stated | 2026-05-22 | NCT07602517 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Janssen Scientific Affairs, LLC | 37 |
| NYU Langone Health | 359 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| NYU Langone Health | New York | United States | 403 |